Across TCGA pan-cancer cohorts, SPINK4 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated SPINK4 data layer compared with 19 for mass-spec protein and 1 for mass-spec protein.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher SPINK4 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SPINK4 expression acts as an unfavorable survival marker.
KIRP, LIHC, and STAD are the cancer types where SPINK4 Mutation most reproducibly stratifies survival.